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Abstract
Background: Clear cell sarcoma of the kidney (CCSK) in adults is extremely rare. Optimal
treatment of adult patients with CCSK remains unclear.
Case presentation: A 22-year-old man presented with a 2-month history of left flank pain. A
color duplex sonography revealed a hypervascular, heterogeneous renal mass. Abdominal and
pelvic computerized tomography showed a heterogeneous mass originating from the lower pole of
the left kidney and infiltrating to the psoas muscle. Further evaluation including bone scan did not
demonstrate any evidence of metastases. A left radical nephrectomy with hilar lymphadenectomy
through an intraperitoneal approach with an anterior subcostal incision was performed. The
histopathological diagnosis of the mass was a clear cell sarcoma of the kidney. No lymph node
metastases were found. Concomitant chemo-radiotherapy was performed. Therapy-related
serious side effects were not observed. There was no evidence of local recurrence or metastases
during the following twenty-four months after therapy.
Conclusion: We believe that the combination therapy is efficacious for preventing the local
recurrence and distant metastases. Accurate diagnosis is very important and therapy must also
include doxorubicin regardless of the disease stage in adult patients with CCSK.
Background
Clear cell sarcoma of the kidney (CCSK) is an uncommon
pediatric neoplasm distinct from Wilms tumor and also
usually tends to metastasize to bones being different from
Wilms tumor [1].
CCSK in adults is extremely rare. Optimal treatment of
adult patients with CCSK remains unclear. Surgery, radio-
therapy and chemotherapy are combined or used sepa-
rately [2-4]. Advanced clear cell renal carcinoma is highly
resistant to traditional cytotoxic chemotherapeutic drugs,
and chemotherapy alone has yielded disappointing
responses in patients with renal cell carcinoma [5]. How-
ever, Argani and colleagues declared that doxorubicin,
regardless of disease stage, was an effective drug in pediat-
ric patients with CCSK [1]. Thus, its differentiation from
clear cell renal carcinoma and undifferentiated adult renal
neoplasm including sarcomatoid renal cell carcinoma is
especially important in adult patients [6].
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Herein, we report a 22-year-old patient with clear cell sar-
coma of the left kidney, who was managed with radical
nephrectomy, radiotherapy and chemotherapy. We think
that our case report might provide additional information
about the treatment of CCSK in adults.
Case presentation
A 22-year-old man presented with a 2-month history of
left flank pain. A color duplex sonography revealed a
hypervascular, heterogeneous renal mass 125 × 156 × 195
mm. in diameter. Abdominal and pelvic computerized
tomography showed a heterogeneous mass originating
from the lower pole of the left kidney and infiltrating to
the psoas muscle (fig. 1). Further evaluation including
bone scan did not demonstrate any evidence of metas-
tases. A left radical nephrectomy with hilar lymphadenec-
tomy through an intraperitoneal approach with an
anterior subcostal incision was performed. The patient
was discharged from hospital on postoperative day 5
without any complication.
Histopathological examination revealed that classic pat-
tern of clear cell sarcoma of the kidney consisted of cells
with fine nuclear chromatin, pale cytoplasm and indis-
tinct cell borders forming nests separated by a fibrovascu-
lar stroma (fig. 2). Stain for cytokeratin was negative while
tumor cells were positive for vimentin. The histopatholog-
ical diagnosis of the mass was a clear cell sarcoma of the
kidney. No lymph node metastases were found. Final
pathologic stage was T3aN0M0 and accepted as stage 2
according to updated National Wilms Tumor Study 5 def-
inition. Concomitant chemo-radiotherapy was per-
formed. The patient underwent adjuvant radiotherapy to
the left nephrectomy bed (4950 cGy). As adjuvant chem-
otherapy, Actinomycin (1.2 mg/m2) with Vincristine (2
mg/m2) and Doxorubicin (30 mg/m2) with Vincristin (2
Computerized tomography shows a heterogeneous mass originating from the lower pole of the left kidney and infiltrating to  the psoas muscle Figure 1
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mg/m2) were administered subsequently for one day
every 3 weeks during one-year period. Therapy-related
serious side effects were not observed. There was no evi-
dence of local recurrence or metastases during the follow-
ing Twenty-four months after therapy.
CCSK is frequently confused with Wilms tumor in chil-
dren. However, Argani and colleagues reported the strik-
ing differences between clear cell sarcoma and Wilms
tumor [1]. The large size, areas of necrosis, a mucoid struc-
ture, and the cyst formation are the important gross fea-
tures of this neoplasm. Stain for cytokeratin is negative
while tumor cells are positive for vimentin in clear cell sar-
coma of the kidney. It usually tends to metastasize to
bones being different from Wilms tumor. It is declared
that in pediatric patients the treatment with doxorubicin,
the presence of necrosis, the stage of the disease, and the
age of the patient at diagnosis were the significant prog-
nostic factors for survival. These findings had been
obtained from the records of the pediatric patients [1].
CCSK is extremely rare neoplasm in adults. Amin and col-
leagues reviewed four new and eight previous cases of
CCSK occurring in adult patients. They reported that clinic
and pathologic features of CCSK did not differ signifi-
cantly between adult and pediatric patients [6]. They also
noted that CCSK was negative for most markers except for
vimentin and this finding was helpful to distinguish it
from undifferentiated adult renal neoplasm including sar-
comatoid renal cell carcinoma [6].
Optimal treatment of adult patients with CCSK still
remains unclear. Surgery, radiotherapy and chemotherapy
are combined or used separately. Benchekroun et al
Classic pattern of clear cell sarcoma of the kidney characterized by cells with fine nuclear chromatin, pale cytoplasm and indis- tinct cell borders forming nests separated by a fibrovascular stroma Figure 2
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reported a patient who underwent surgery followed by
combination chemotherapy with cisplatin and doxoru-
bicin and had no metastases 4 years later, but the metas-
tases occurred within months in two patients who did not
receive chemotherapy or radiotherapy after surgery [2]. In
addition, Bhayani et al noted that a patient treated with
surgery and combination chemotherapy (actinomycin,
vincristine and doxorubicin) was disease-free at 12
months postoperatively [3]. In a report recently published
by Rosso and colleagues, they treated a patient with sur-
gery alone and stated that CCSK has a high resistance
against radiation and chemotherapy [4].
Advanced clear cell renal carcinoma is highly resistant to
traditional cytotoxic chemotherapeutic drugs and espe-
cially interleukin-2 and interferon alpha, along with
selected chemotherapeutic agents have proven to be the
most effective, with response rates averaging about 20 per-
cent [5]. However, Argani and colleagues declared that
doxorubicin, regardless of disease stage, was an effective
drug in CCSK and also pointed that the survival rate was
98% and 69% for the pediatric patients with stage 1 dis-
ease and for all stages, respectively [1]. Thus, its differenti-
ation from clear cell renal carcinoma and undifferentiated
adult renal neoplasm including sarcomatoid renal cell
carcinoma is especially important in adult patients. Our
22-year-old male patient received radiotherapy and com-
bination chemotherapy with actinomycin, vincristine and
doxorubicin after radical nephrectomy and lymph node
dissection. Twenty-four months following surgery and
concomitant chemoradiotherapy there was no evidence of
local recurrence or metastases.
Conclusion
We believe that the combination therapy is efficacious for
preventing the local recurrence and distant metastases. As
Argani and colleagues suggested in pediatric patients,
accurate diagnosis is very important and therapy must
also include doxorubicin regardless of the disease stage in
adult patients with CCSK.
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